CSF proteomics for predicting response to treatment in patients with primary and secondary central nervous system lymphoma

被引:0
|
作者
Wilding, Hannah E.
Aastha, Aastha
Mikolajewicz, Nicholas
Macedo Filho, Leonardo
Bhanja, Debarati
Heebner, Madison
Khan, Shahbaz
Ignatchenko, Vladimir
Ozair, Ahmad
Ahluwalia, Manmeet Singh
Glantz, Michael J.
Kislinger, Thomas
Mansouri, Alireza
机构
[1] Penn State Coll Med, University Pk, PA USA
[2] Univ Toronto, Toronto, ON, Canada
[3] Penn State Coll Med, Hershey, PA USA
[4] Univ Hlth Network, Toronto, ON, Canada
[5] Johns Hopkins Univ, Baltimore, MD USA
[6] Baptist Hlth South Florida, Miami Canc Inst, Miami, FL USA
[7] Penn State Milton S Hershey Med Ctr, Hershey, PA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e19083
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Significance of treatment response when managing patients with primary central nervous system lymphoma
    Chan, Henry
    Moraes, Fabio Ynoe
    Berlin, Alejandro
    Crump, Michael
    Mason, Warren
    Laperriere, Normand
    Kuruvilla, John
    Prica, Anca
    [J]. LEUKEMIA & LYMPHOMA, 2019, 60 (02) : 349 - 357
  • [2] Treatment of Primary Central Nervous System Lymphoma in Immunocompetent Patients
    Garcilazo-Reyes, Ytel
    Alentorn, Agusti
    Duran-Pena, Alberto
    Khe Hoang-Xuan
    Houillier, Caroline
    [J]. CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2019, 21 (08)
  • [3] DIAGNOSIS AND TREATMENT OF PATIENTS WITH PRIMARY LYMPHOMA OF THE CENTRAL NERVOUS SYSTEM
    Sole Rodriguez, M.
    Zapata Bautista, R.
    Palma Vallellano, A. J.
    [J]. HAEMATOLOGICA, 2018, 103 : 340 - 341
  • [4] Treatment of primary central nervous system lymphoma in AIDS patients
    Huelva, FJC
    Sandubete, EC
    Garcia, JLG
    [J]. MEDICINA CLINICA, 1998, 111 (14): : 559 - 559
  • [5] Treatment of Primary Central Nervous System Lymphoma in Immunocompetent Patients
    Ytel Garcilazo-Reyes
    Agusti Alentorn
    Alberto Duran-Pena
    Khê Hoang-Xuan
    Caroline Houillier
    [J]. Current Treatment Options in Neurology, 2019, 21
  • [6] Diffusion-Weighted Imaging for Predicting and Monitoring Primary Central Nervous System Lymphoma Treatment Response
    Huang, W. -Y.
    Wen, J. -B.
    Wu, G.
    Yin, B.
    Li, J. -J.
    Geng, D. -Y.
    [J]. AMERICAN JOURNAL OF NEURORADIOLOGY, 2016, 37 (11) : 2010 - 2018
  • [7] Omission of etoposide in the treatment of haemophagocytic lymphohistiocytosis secondary to primary central nervous system lymphoma with satisfactory response
    Laches, Rachel
    Hall, Robert J.
    Chaffin, Joanna
    Hahn, Paulette
    [J]. BMJ CASE REPORTS, 2024, 17 (07)
  • [8] Treatment of primary central nervous system lymphoma
    Ekenel M.
    DeAngelis L.M.
    [J]. Current Treatment Options in Neurology, 2007, 9 (4) : 271 - 282
  • [9] Treatment of primary central nervous system lymphoma
    Shah, GD
    DeAngelis, LM
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2005, 19 (04) : 611 - +
  • [10] Treatment of primary central nervous system lymphoma
    DeAngelis, LM
    Hormigo, A
    [J]. SEMINARS IN ONCOLOGY, 2004, 31 (05) : 684 - 692